Kairos Pharma, Ltd. (KAPA)

Last Closing Price: 1.58 (2026-09-02)

Gross Profit (Quarterly)

Gross Profit: Revenues from operations less the associated costs.

Kairos Pharma, Ltd. (KAPA) Gross Profit data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
$-1.39M
--
Gross Profit
--
$1.42M
$-1.42M
$0.03M
$-1.39M
$-1.39M
$-1.39M
$-1.39M
$-1.39M
$-1.39M
$-1.42M
$-1.18M
21.42M
21.42M
$-0.06
$-0.06
Balance Sheet Financials
$3.17M
--
$1.28M
$4.46M
$0.27M
--
--
$0.27M
$4.19M
$4.19M
$4.19M
21.42M
Cash Flow Statement Financials
$-2.05M
--
$0.18M
$4.49M
$2.63M
$-1.86M
--
--
--
Fundamental Metrics & Ratios
11.98
--
--
--
--
--
--
--
--
--
--
$-2.05M
--
--
--
--
--
--
--
-33.12%
-33.12%
-31.15%
-33.12%
$0.20
$-0.10
$-0.10